Organization (Nonprofit)
Asan Foundation
ClinicalTrials.gov lists Asan Foundation as lead sponsor of 581 trials, counting the companies grouped under it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. Companies grouped under this one are not included. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers Asan Foundation and 2 companies grouped under it: 581 lead-sponsored trials (3 its own, 578 in the grouped companies) and 3 legal-entity registrations (1 its own, 2 in the grouped companies).
Companies grouped under this page (2)
Shown in this order: most lead trials first.
| Company | Lead trials | Legal entities |
|---|---|---|
| Asan Medical Center | 576 | 1 |
| Gangneung Asan Hospital | 2 | 1 |
Disease areas (369)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Stomach Neoplasms | 35 |
| Breast Neoplasms | 31 |
| Liver Neoplasms | 30 |
| Colorectal Neoplasms | 26 |
| Lymphoma | 26 |
Showing 5 of 369 disease areas.
Trials by start year as sponsor or collaborator (3)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2018 | 1 |
| 2017 | 1 |
| 2016 | 1 |
Recruitment duration, a model prediction: none of the 3 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 1 of 2 hit target (n=2) | 1 of 2 on time (n=2) |
Journals published in (525)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 77 |
| The New England journal of medicine | 60 |
| Blood | 54 |
| Lancet (London, England) | 27 |
| Annals of oncology : official journal of the European Society for Medical Oncology | 21 |
Showing 5 of 525 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 76 | 43 | 2025-11-18 |
Organization relationships (100)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Samsung (South Korea) | Co sponsors trial with | 47 |
| Yonsei University | Co sponsors trial with | 44 |
| Korea University | Co sponsors trial with | 16 |
| The Catholic University of Korea Catholic Medical Center | Co sponsors trial with | 14 |
| Ulsan University Hospital | Co sponsors trial with | 12 |
Showing 5 of 100 relationships.
Latest dated events (821)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-10-15 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-07-03 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-07-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-07-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-06-23 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 821 events.
Biomarker capability evidence (2)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| APOE | Trial sponsor | Named in trial inclusion criteria |
| APOE | Trial sponsor | Mentioned in trial text |
Biomarkers this organization publishes on (960)
Shown in this order: most publications first.
Showing 5 of 960 biomarkers.
On Scientist.com
Asan Foundation is listed as a research supplier in the Scientist.com network.
Service areas
ASAN Medical Center offers research, efficacy, bioavailibity, pharmacokinetic, and pharmacodynamic modeling services.
- Website
- eng.amc.seoul.kr
Not on this page
Checked, with nothing recorded for this organization: related companies not grouped here, active development programs, approved assets, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.
Work with ASAN Medical Center on Scientist.com
For prices, more details, or to contact ASAN Medical Center, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.